Skip to main content
Premium Trial:

Request an Annual Quote

Advion, Bruker Ink Mass Spec Co-Marketing Deal

NEW YORK (GenomeWeb News) – Advion BioSystems announced today that it has signed a co-marketing agreement with Bruker Daltonik to sell the firm’s TriVersa NanoMate nanoelectrospray source with Bruker’s mass spectrometers.
 
Under the agreement, the firms have exchanged instruments for applications development and product demonstration. In addition, the companies will co-promote their products at industry tradeshows and conferences, Ithaca, NY-based Advion said in a statement.
 
Advion said that the TriVersa NanoMate combines the benefits of liquid chromatography, fraction collection, and chip-based infusion in a single system.
 
“Bruker’s market position in the life sciences allows Advion’s customers more flexibility to use its equipment as well as opening greater market potential for future sales in proteomic, biomarker, and metabolism applications,” said Jack Henion, Advion’s chief scientific officer.
 
Further terms of the alliance were not disclosed.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.